Speech latency may predict schizophrenia trial response, boosting drug-placebo separation
Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing sample size requirements and enhancing statistical outcomes. By using speech latency, participants who ...
Feb 12, 2026
0
0









